These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28240174)

  • 1. Hormone Therapy and Delivery Strategies against Cardiovascular Diseases.
    Acharya G; Hasan N; Yoo JW; Lee CH
    Curr Pharm Biotechnol; 2017; 18(4):285-302. PubMed ID: 28240174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perspective and potential of oral lipid-based delivery to optimize pharmacological therapies against cardiovascular diseases.
    Rao S; Tan A; Thomas N; Prestidge CA
    J Control Release; 2014 Nov; 193():174-87. PubMed ID: 24852093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stent-mediated gene and drug delivery for cardiovascular disease and cancer: A brief insight.
    Krishnagopal A; Reddy A; Sen D
    J Gene Med; 2017 May; 19(5):. PubMed ID: 28370939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Drug Delivery for Cardiovascular and Cerebrovascular Diseases.
    Luan J; Zhai G
    Curr Drug Targets; 2016; 17(4):467-74. PubMed ID: 25882222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle Systems for Stem Cell Applications.
    Li X; Liu X; Shi D; Wen X
    J Biomed Nanotechnol; 2015 Jul; 11(7):1107-23. PubMed ID: 26307835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nitric oxide on stem cell therapy.
    Wang W; Lee Y; Lee CH
    Biotechnol Adv; 2015 Dec; 33(8):1685-96. PubMed ID: 26394194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.
    Sharma PA; Maheshwari R; Tekade M; Tekade RK
    Curr Pharm Des; 2015; 21(30):4465-78. PubMed ID: 26354926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanotechnology for protein delivery: Overview and perspectives.
    Yu M; Wu J; Shi J; Farokhzad OC
    J Control Release; 2016 Oct; 240():24-37. PubMed ID: 26458789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stents as a platform for drug delivery.
    Lei L; Guo SR; Chen WL; Rong HJ; Lu F
    Expert Opin Drug Deliv; 2011 Jun; 8(6):813-31. PubMed ID: 21548713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the cell cycle machinery for the treatment of cardiovascular disease.
    Bicknell KA; Surry EL; Brooks G
    J Pharm Pharmacol; 2003 May; 55(5):571-91. PubMed ID: 12831500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical aspects of drug eluting stents.
    Deconinck E; Sohier J; De Scheerder I; Van den Mooter G
    J Pharm Sci; 2008 Dec; 97(12):5047-60. PubMed ID: 18384155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advancements in the cardiovascular drug carriers.
    Singh B; Garg T; Goyal AK; Rath G
    Artif Cells Nanomed Biotechnol; 2016; 44(1):216-25. PubMed ID: 25046615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery.
    Vaidya B; Gupta V
    J Control Release; 2015 Aug; 211():118-33. PubMed ID: 26036906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.
    Aizik G; Grad E; Golomb G
    Drug Deliv Transl Res; 2018 Aug; 8(4):868-882. PubMed ID: 29058205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-based therapeutic strategies for mitochondrial dysfunction in cardiovascular disease.
    Suzuki I; Xing H; Giblin J; Ashraf A; Chung EJ
    J Biomed Mater Res A; 2024 Jun; 112(6):895-913. PubMed ID: 38217313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porous nanoparticles in drug delivery systems.
    Arayne MS; Sultana N
    Pak J Pharm Sci; 2006 Apr; 19(2):158-69. PubMed ID: 16751130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineered nanoparticles as precise drug delivery systems.
    Yih TC; Al-Fandi M
    J Cell Biochem; 2006 Apr; 97(6):1184-90. PubMed ID: 16440317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases.
    Goradel NH; Hour FG; Negahdari B; Malekshahi ZV; Hashemzehi M; Masoudifar A; Mirzaei H
    J Cell Biochem; 2018 Jan; 119(1):95-104. PubMed ID: 28543595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.